{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:38:24Z","timestamp":1792460304378,"version":"4.5.0"},"reference-count":49,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Biochem &amp;amp; Molecular Tox"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>This research explored the anticancer activities of the glucagon\u2010like peptide\u20101 receptor agonist (GLP1Ra) liraglutide using MCF7 breast and PC\u20103 prostate cancer cell lines. The study focused on key molecular pathways related to glycolysis and oxidative stress alongside adipokine profiles. The expression of GLP1R and its downstream signalling components (cAMP and PKA) was quantified in untreated and treated cells. Alterations in cell cycle and cell apoptosis were evaluated by a flow cytometer. Expression of oncogenic (CCND1, CCND3, BCL2, survivin) and tumour suppressor (p21, p27, BAX, Caspase\u20103) proteins, the PI3KAkt\/mTOR axis and glycolytic regulators (HIF\u2010\u03b1, LDHA, PDHK1, PDH) was examined by Western blot analysis. Adipokine concentrations (adiponectin, leptin, resistin), pro\u2010oxidants (ROS\/RNS, MDA, protein carbonyls) and antioxidants (GSH, CAT) were assessed using ELISA. Liraglutide treatment led to pronounced upregulation of GLP1R expression and activation of cAMP\/PKA signalling in both cancer cell lines. Antiproliferative effects were evident through induced apoptosis and cell cycle arrest alongside inhibition of CCND1, CCND3, BCL2 and survivin with increased p21, p27, BAX and Caspase\u20103 expression. The PI3K\/Akt\/mTOR pathway was suppressed, while its negative regulators, PTEN and AMPK\u03b1, were upregulated. Liraglutide also shifted metabolic activity towards oxidative phosphorylation by suppressing HIF\u2010\u03b1, LDHA and PDHK1, whereas PDH levels increased. Additionally, liraglutide raised adiponectin levels while reducing leptin and resistin. Oxidative stress markers increased substantially, accompanied by a decrease in antioxidant levels in both cell lines. Liraglutide induced anticancer effects in breast and prostate cancer cells, possibly by promoting oxidative phosphorylation, modulating adipokines and inducing oxidative stress\u2010mediated apoptosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jbt.70913","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:18:54Z","timestamp":1779171534000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The GLP\u20101 Receptor Agonist Liraglutide Promotes Anticancer Activities in MCF7 Breast and PC\u20103 Prostate Cancer Cells by Modulating Glycolysis, Oxidative Stress and Adipokines"],"prefix":"10.1002","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4267-1016","authenticated-orcid":false,"given":"Bassem","family":"Refaat","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences Umm Al\u2010Qura University Makkah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Elzubier","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences Makkah Colleges Makkah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhmed","family":"Aslam","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences Umm Al\u2010Qura University Makkah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakir","family":"Idris","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences Umm Al\u2010Qura University Makkah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesam F.","family":"Farrash","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences Umm Al\u2010Qura University Makkah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2020-0509"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2025.114406"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15204957"},{"issue":"5","key":"e_1_2_12_6_1","article-title":"An Update to Hallmarks of Cancer","volume":"14","author":"Ravi S.","year":"2022","journal-title":"Cureus"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-021-02074-9"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-024-10192-9"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.108011"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s43046-025-00261-7"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14246028"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44337-024-00131-6"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1370800"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15133473"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.7150\/jca.86283"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2023.0445"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2024.02.005"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2024.2329368"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01474-4"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03831-8"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252212137"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112911"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174250"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112958"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1590\/s1677-5538.ibju.2018.0261"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells13010065"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1465881"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.21305"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1585-0"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4104-9"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2017-00461"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-021-00560-z"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101923"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1169"},{"issue":"2","key":"e_1_2_12_35_1","first-page":"91","article-title":"Glucagon\u2010Like Peptide\u20101 Analogues Inhibit Proliferation and Increase Apoptosis of Human Prostate Cancer Cells In Vitro","volume":"125","author":"Li X.","year":"2017","journal-title":"Experimental and Clinical Endocrinology & Diabetes"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173102"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/1559325821995651"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14061538"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120442"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13247"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1947"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/1178223419898458"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174139"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom13071084"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/15353702231191206"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-022-02319-y"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2024.10.001"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79345-4"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14855"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108899"}],"container-title":["Journal of Biochemical and Molecular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbt.70913","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbt.70913","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbt.70913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:04:58Z","timestamp":1782108298000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jbt.70913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1002\/jbt.70913"],"URL":"https:\/\/doi.org\/10.1002\/jbt.70913","archive":["Portico"],"relation":{},"ISSN":["1095-6670","1099-0461"],"issn-type":[{"value":"1095-6670","type":"print"},{"value":"1099-0461","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"2025-10-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70913"}}